ATE440604T1 - Verfahren zum evaluieren und behandeln von krebs - Google Patents
Verfahren zum evaluieren und behandeln von krebsInfo
- Publication number
- ATE440604T1 ATE440604T1 AT05254157T AT05254157T ATE440604T1 AT E440604 T1 ATE440604 T1 AT E440604T1 AT 05254157 T AT05254157 T AT 05254157T AT 05254157 T AT05254157 T AT 05254157T AT E440604 T1 ATE440604 T1 AT E440604T1
- Authority
- AT
- Austria
- Prior art keywords
- cancer
- evaluation
- treatment
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/883,436 US20050003422A1 (en) | 2003-07-01 | 2004-07-01 | Methods for assessing and treating cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE440604T1 true ATE440604T1 (de) | 2009-09-15 |
Family
ID=35058443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05254157T ATE440604T1 (de) | 2004-07-01 | 2005-07-01 | Verfahren zum evaluieren und behandeln von krebs |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20050003422A1 (de) |
| EP (1) | EP1611890B1 (de) |
| JP (1) | JP2006014739A (de) |
| KR (1) | KR20060048684A (de) |
| CN (1) | CN1721553A (de) |
| AR (1) | AR049564A1 (de) |
| AT (1) | ATE440604T1 (de) |
| AU (1) | AU2005202520A1 (de) |
| BR (1) | BRPI0502433A (de) |
| CA (1) | CA2512493A1 (de) |
| DE (1) | DE602005016189D1 (de) |
| DK (1) | DK1611890T3 (de) |
| MX (1) | MXPA05007207A (de) |
| PT (1) | PT1611890E (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005201935B2 (en) * | 2004-05-06 | 2012-04-26 | Veridex, Llc | Prognostic for hematological malignancy |
| WO2008054598A2 (en) * | 2006-09-29 | 2008-05-08 | Schering Corporation | Panel of biomarkers for prediction of fti efficacy |
| JP2011512785A (ja) * | 2007-03-12 | 2011-04-28 | ベリデックス・エルエルシー | ファルネシルトランスフェラーゼ治療に対する急性骨髄性白血病応答を決定する方法 |
| US7932036B1 (en) | 2008-03-12 | 2011-04-26 | Veridex, Llc | Methods of determining acute myeloid leukemia response to treatment with farnesyltransferase |
| CA2659638C (en) * | 2008-03-21 | 2013-07-23 | Mission Itech Hockey Ltd. | Helmet for a hockey or lacrosse player |
| CN104878086A (zh) * | 2009-02-11 | 2015-09-02 | 卡里斯Mpi公司 | 肿瘤的分子谱分析 |
| JP6034784B2 (ja) * | 2010-07-28 | 2016-11-30 | ジャンセン ダイアグノスティックス，エルエルシー | ファルネシルトランスフェラーゼ阻害剤による治療に対する急性白血病応答を判定するための方法 |
| US11559540B2 (en) | 2010-07-28 | 2023-01-24 | Janssen Pharmaceutica Nv | Method of determining acute myeloid leukemia response to treatment with farnesyltransferase inhibitors |
| WO2017184968A1 (en) * | 2016-04-22 | 2017-10-26 | Kura Oncology, Inc. | Methods of selecting cancer patients for treatment with farnesyltransferase inhibitors |
| MX2020001207A (es) * | 2017-08-07 | 2020-03-20 | Kura Oncology Inc | Metodos de tratamiento del cancer con inhibidores de farnesiltransferasa. |
| US10806730B2 (en) | 2017-08-07 | 2020-10-20 | Kura Oncology, Inc. | Methods of treating cancer with farnesyltransferase inhibitors |
| US20210231666A1 (en) * | 2018-06-06 | 2021-07-29 | La Jolla Institute For Immunology | Cd33 monocytes as a biomarker |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5238808A (en) | 1984-10-31 | 1993-08-24 | Igen, Inc. | Luminescent metal chelate labels and means for detection |
| US5221605A (en) | 1984-10-31 | 1993-06-22 | Igen, Inc. | Luminescent metal chelate labels and means for detection |
| US5310687A (en) | 1984-10-31 | 1994-05-10 | Igen, Inc. | Luminescent metal chelate labels and means for detection |
| ES2175137T3 (es) | 1995-12-08 | 2002-11-16 | Janssen Pharmaceutica Nv | Derivados de (imidazol-5-il)metil-2-quinolinona como inhibidores de laproteina farnesil-transferasa. |
| US5874442A (en) | 1995-12-22 | 1999-02-23 | Schering-Plough Corporation | Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease |
| JP2001505548A (ja) | 1996-12-20 | 2001-04-24 | トヴァリシェストヴォ エス オグラニチェンノイ オトヴェトストヴェンノストジュ“タブジュファーム” | 凍結乾燥ハイドロクロライド−１β，１０β−エポキシ−１３−ジメチルアミノ−グアヤ−３（４）−エン−６，１２−オリドの生成方法および装置 |
| US6303654B1 (en) | 1998-03-12 | 2001-10-16 | Wisconsin Alumni Research Foundation | Acyclic monoterpenoid derivatives |
| US6335170B1 (en) * | 1999-02-22 | 2002-01-01 | Torben F. Orntoft | Gene expression in bladder tumors |
| JO2361B1 (en) | 2000-06-22 | 2006-12-12 | جانسين فارماسيوتيكا ان. في | Enaniumer 1,2-anylated quinoline inhibitor for the transporter - farnesyl |
| MXPA04004072A (es) * | 2001-10-30 | 2004-09-06 | Johnson & Johnson | Metodos para valorar y tratar leucemia. |
| US7473526B2 (en) * | 2002-03-29 | 2009-01-06 | Veridex, Llc | Breast cancer prognostic portfolio |
| US20030224422A1 (en) * | 2002-04-08 | 2003-12-04 | St. Jude Children's Research Hospital, Inc. | Pre-and post therapy gene expression profiling to identify drug targets |
| EP1502962A3 (de) * | 2003-07-01 | 2006-01-11 | Veridex, LLC | Methoden zur Einschätzung und zur Behandlung von Krebserkrankungen |
-
2004
- 2004-07-01 US US10/883,436 patent/US20050003422A1/en not_active Abandoned
-
2005
- 2005-06-09 AU AU2005202520A patent/AU2005202520A1/en not_active Abandoned
- 2005-06-23 CA CA002512493A patent/CA2512493A1/en not_active Abandoned
- 2005-06-29 KR KR1020050056876A patent/KR20060048684A/ko not_active Application Discontinuation
- 2005-06-30 AR ARP050102730A patent/AR049564A1/es unknown
- 2005-06-30 MX MXPA05007207A patent/MXPA05007207A/es unknown
- 2005-06-30 JP JP2005192550A patent/JP2006014739A/ja not_active Abandoned
- 2005-07-01 DE DE602005016189T patent/DE602005016189D1/de active Active
- 2005-07-01 BR BRPI0502433-1A patent/BRPI0502433A/pt not_active IP Right Cessation
- 2005-07-01 PT PT05254157T patent/PT1611890E/pt unknown
- 2005-07-01 AT AT05254157T patent/ATE440604T1/de not_active IP Right Cessation
- 2005-07-01 DK DK05254157T patent/DK1611890T3/da active
- 2005-07-01 CN CNA2005100822115A patent/CN1721553A/zh active Pending
- 2005-07-01 EP EP05254157A patent/EP1611890B1/de not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005202520A1 (en) | 2006-01-19 |
| PT1611890E (pt) | 2009-09-29 |
| KR20060048684A (ko) | 2006-05-18 |
| US20050003422A1 (en) | 2005-01-06 |
| AR049564A1 (es) | 2006-08-16 |
| DE602005016189D1 (de) | 2009-10-08 |
| MXPA05007207A (es) | 2006-05-22 |
| DK1611890T3 (da) | 2009-11-16 |
| CA2512493A1 (en) | 2006-01-01 |
| EP1611890A1 (de) | 2006-01-04 |
| CN1721553A (zh) | 2006-01-18 |
| BRPI0502433A (pt) | 2006-04-04 |
| JP2006014739A (ja) | 2006-01-19 |
| EP1611890B1 (de) | 2009-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE440604T1 (de) | Verfahren zum evaluieren und behandeln von krebs | |
| DE602005004280D1 (de) | Verfahren zum ziehen von sic-einkristallen und sic-einkristall | |
| DE602007006479D1 (de) | Verfahren und vorrichtungen zur behandlung von mehreren bohrlochintervallen | |
| DE602006012823D1 (de) | Vorrichtung und verfahren zum neusynthetisieren von signalen | |
| ATE489955T1 (de) | Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten | |
| DE602005012917D1 (de) | Verfahren und Vorrichtung zum Umformen | |
| DE602007012538D1 (de) | Verfahren und Vorrichtung zur Durchführung delegierter Transaktionen | |
| DE602005017318D1 (de) | Verfahren und Vorrichtung zum Bereitstellen von Entwurfsdaten | |
| DE602006006952D1 (de) | Vorrichtung und Verfahren zur Personenidentifizierung | |
| DE112005003862A5 (de) | Verfahren und Vorrichtungen zum Bereitstellen von Stapelchipelementen | |
| DE602006003973D1 (de) | Verfahren und Vorrichtung zur Wasserbehandlung | |
| DE602005011934D1 (de) | Vorrichtung zum Einfangen von Kügelchen und Verfahren und Vorrichtung zum Anordnen von Kügelchen | |
| DE602005000515D1 (de) | Reissverschluss und Verfahren zum Herstellen desselben | |
| DE602006019769D1 (de) | Verfahren und gerät zum falten von artikeln | |
| DE602005017898D1 (de) | Verfahren und kit zum nachweis von histamin | |
| DE112008003045A5 (de) | Verfahren und Vorrichtung zum Behandeln von Schlamm | |
| ATE508984T2 (de) | Chemisches verfahren und vorrichtung | |
| ATE393388T1 (de) | Verfahren zum detektieren und entfernen von fremdkörpern | |
| DE102005033305A8 (de) | Werkzeug und Verfahren zum Bearbeiten von Geröll | |
| DE112007003786A5 (de) | Verfahren und Vorrichtung zum Durchführen von Auswahl-Operationen | |
| DE602006013148D1 (de) | Verfahren zum austrocknen und/oder entlauben von glyphosateresistenten kulturen | |
| DE602006014688D1 (de) | Vorrichtung und verfahren | |
| DE602005013541D1 (de) | Verfahren und gerät zum trimmen von faserigen substraten | |
| AT504810A3 (de) | Vorrichtung und verfahren zum herstellen von pastillen | |
| DE112007002256A5 (de) | Heizvorrichtung und Verfahren zum Heizen von Gegenständen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |